Drs. Baldwin and Harper provide an update on the evolving management of Acne Vulgaris and Rosacea, reviewing changes in treatment strategies, emerging therapies, and practical approaches to patient care. Their discussion emphasizes evidence-based prescribing, antibiotic stewardship, and innovations that may reshape future treatment paradigms.
Topics Covered
- Evolving treatment strategies for moderate-to-severe acne
- Initiating treatment with topical therapies before considering oral antibiotics
- The importance of antibiotic stewardship in acne management
- Investigational therapies, including fatty acid synthase inhibitors and acne vaccines aimed at reducing inflammation and preventing scarring
- Evidence supporting low-dose, extended-release minocycline for rosacea
- The anti-inflammatory role of tetracyclines in rosacea treatment
- Use of very low-dose isotretinoin in selected patients
- Challenges and treatment considerations for neurogenic and ocular rosacea
Explore Related Resources